Sertraline Hydrochloride Tablet
Product Images NDC 31722-147

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 31722-147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg 30s

Label for Sertraline Hydrochloride Tablets USP 100 mg by Camber Pharmaceuticals, Inc. The label shows the NDC 31722-147-30, indicates 30 oral tablets, and includes storage instructions at 20°C to 25°C. It notes the medication guide availability and states the product is prescription only.*

FDA Label Image

100 mg 500s

Label for Sertraline Hydrochloride Tablets, USP 100 mg oral tablets by Camber Pharmaceuticals, Inc. The label states 500 tablets per container, Rx only, with dosage and storage instructions. Manufactured by Ascent Pharmaceuticals, Inc. and labeled for Camber Pharmaceuticals, Inc.*

FDA Label Image

100 mg 90s

Label for Sertraline Hydrochloride Tablets, USP 100 mg oral tablets by Camber Pharmaceuticals, Inc. The label indicates a package size of 90 tablets with a prescription-only status. It includes dosage instructions referencing prescribing information, storage conditions at 20°C to 25°C, and medication guide availability. The label notes manufacturing by Ascent Pharmaceuticals, Inc. and Camber Pharmaceuticals, Inc.*

FDA Label Image

25 mg 30s

Packaging label for Sertraline Hydrochloride Tablets, USP 25 mg by Camber Pharmaceuticals, Inc. The label states the NDC 31722-145-30 and that the package contains 30 tablets. It includes instructions for pharmacists to dispense the medication guide separately, storage conditions, and manufacturer information.*

FDA Label Image

25 mg 500s

Label for Sertraline Hydrochloride Tablets, USP 25 mg, by Camber Pharmaceuticals, Inc. The label indicates this is an oral tablet dosage form with a quantity of 500 tablets. It includes storage instructions, dosage strength, a barcode, and pharmacist dispensing guidance. The product is prescription only and manufactured for Camber Pharmaceuticals, Inc.*

FDA Label Image

25 mg 90s

Label for Sertraline Hydrochloride Tablets, USP 25 mg by Camber Pharmaceuticals, Inc. The label states the product is an oral tablet available in a 90-tablet supply. It includes dosage strength, NDC 31722-145-90, dispensing instructions for pharmacists, storage conditions, and manufacturer information.*

FDA Label Image

50 mg 30s

Label for Sertraline Hydrochloride Tablets, USP 50 mg by Camber Pharmaceuticals, Inc. The label indicates 30 tablets in the package, prescription use only, with storage instructions and directions for pharmacists to dispense a medication guide. It includes the NDC number 31722-146-30 and manufacturer information.*

FDA Label Image

50 mg 500s

Label for Sertraline Hydrochloride Tablets USP 50 mg by Camber Pharmaceuticals, Inc. The oral tablet package contains 500 tablets, with a note for pharmacists to dispense the Medication Guide separately to patients. The label includes dosage details, storage instructions, and manufacturing information.*

FDA Label Image

50 mg 90s

Packaging label for Sertraline Hydrochloride Tablets, USP 50 mg by Camber Pharmaceuticals, Inc. The oral tablet package contains 90 tablets. Label includes NDC 31722-146-90, pharmacist dispensing instructions, storage conditions, manufacturer and labeler information, and dosage note. The label specifies that each film-coated tablet contains 56 mg sertraline hydrochloride equivalent to 50 mg sertraline.*

FDA Label Image

Serioussymptoms

A medication information panel listing possible side effects or adverse reactions associated with sertraline hydrochloride tablets by Camber Pharmaceuticals, Inc. The text itemizes symptoms such as high fever, rapid changes in heart rate or blood pressure, uncontrolled muscle spasms, confusion, stiff muscles, and loss of consciousness (passing out).*

FDA Label Image

Commonsideeffects

Text excerpt from a medication guide or prescribing information listing possible side effects or adverse reactions, including nausea, loss of appetite, diarrhea, indigestion, increased sweating, tremor or shaking, agitation, changes in sleep habits, sexual problems, fatigue, and anxiety.*

FDA Label Image

Healthproblems

A partial drug facts or warnings text panel listing medical conditions and concerns including liver problems, heart problems, bipolar disorder or mania, kidney problems, seizures or convulsions, low sodium levels, stroke history, high blood pressure, and bleeding problems.*

FDA Label Image

Struct

Chemical structure diagram of sertraline hydrochloride, showing the arrangement of its atoms including chlorines on the aromatic ring and a hydrochloride group.*

FDA Label Image

Symptoms 1

A partial text panel listing warning signs and behavioral symptoms related to mental health, such as suicidal thoughts, aggressive behavior, worsening depression, agitation, and anxiety. The text consists of two columns with bullet points highlighting various symptoms.*

FDA Label Image

Symptoms 2

This text panel lists various symptoms and adverse reactions associated with the medication sertraline hydrochloride, including agitation, hallucinations, coma, changes in mental status, racing heartbeat, blood pressure changes, coordination problems, nausea, vomiting, diarrhea, sweating, fever, and muscle rigidity.*

FDA Label Image

Symptoms 4

A partial text panel listing potential side effects or symptoms including greatly increased energy, racing thoughts, unusually grand ideas, severe trouble sleeping, reckless behavior, excessive happiness or irritability, and talking more or faster than usual.*

FDA Label Image

Symptoms 8

A partial text panel listing potential side effects, including headache, weakness or feeling unsteady, confusion, problems concentrating or thinking, and memory problems. The text is in black font on a white background with bullet points separating the items.*

FDA Label Image

Table1

A table showing recommended daily dosages of sertraline hydrochloride for various indications including MDD, OCD, PD, PTSD, and SAD. It lists starting doses and therapeutic ranges for adults and pediatric patients, categorized by age and condition.*

FDA Label Image

Table2

A data table titled 'Risk Differences of the Number of Cases of Suicidal Thoughts or Behaviors in the Pooled Placebo-Controlled Trials of Antidepressants in Pediatric and Adult Patients' showing age ranges compared to the difference in suicidal thoughts or behaviors per 1000 patients treated with drug versus placebo, with increased risk under 25 years and decreased risk in older age groups.*

FDA Label Image

Table3

A data table listing common adverse reactions in adults from pooled placebo-controlled trials comparing sertraline hydrochloride to placebo. It covers various disorder categories including cardiac, eye, gastrointestinal, general disorders, metabolism, nervous system, psychiatric, reproductive, and skin disorders, showing the percentage of subjects affected in each group.*

FDA Label Image

Table4

A data table titled 'Most Common Sexual Adverse Reactions (≥2% and twice placebo) in Men or Women from sertraline hydrochloride Pooled Controlled Trials in Adults with MDD, OCD, PD, PTSD, SAD, and PMDD.' It compares the incidence percentages of sexual adverse reactions between sertraline hydrochloride and placebo groups for men and women. Reactions include ejaculation failure, decreased libido, erectile dysfunction, ejaculation disorder, and male sexual dysfunction in men, and decreased libido in women.*

FDA Label Image

Table5

A data table listing clinically significant drug interactions with sertraline hydrochloride. It details drug classes, clinical impacts, intervention recommendations, and example drugs, including Monoamine Oxidase Inhibitors, Pimozide, serotonergic drugs, anticoagulants, drugs bound to plasma protein, CYP2D6 metabolizers, phenytoin, and drugs affecting the QTc interval.*

FDA Label Image

Treatment

Text panel listing six mental health conditions: Major Depressive Disorder (MDD), Panic Disorder, Social Anxiety Disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), and Premenstrual Dysphoric Disorder (PMDD). This text likely relates to indications for a prescription drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.